Several protein kinase inhibitors (ATC code: L01E) used in anticancer therapy were also found to be associated with MRONJ, with sunitinib exacerbating MRONJ in renal cell carcinoma [39]. The gene discussed is WEE1; the disease is hereditary clear cell renal cell carcinoma.